SCHEMBL20977906

SCHEMBL20977906

COc1cc(F)c2c(c1)cc(C)n2C(=O)OC(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
AKR1C3 P42330 4/20 0.36
AKR1C2 P52895 4/20 0.36
TUBB1 Q9H4B7 1/20 0.35
CPS1 P31327 3/20 0.33
PTGS2 P35354 4/20 0.32
CYP1A2 P05177 2/20 0.32
HPGD P15428 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
NPC1 O15118 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
RAB9A P51151 1/20 0.32
THRB P10828 1/20 0.32
HDAC1 Q13547 1/20 0.32
PTGS1 P23219 2/20 0.31
CDC42 P60953 1/20 0.31
RAC1 P63000 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18054357 0.87 PTGS2 (0.36) TDP1AKR1C3AKR1C2PTGS2SMN1; SMN2
SCHEMBL18052939 0.86 AKR1C3 (0.39) L3MBTL1AKR1C3AKR1C2TUBB1CPS1
SCHEMBL20224058 0.86
SCHEMBL18052933 0.84 CA12 (0.37) L3MBTL1HPGDSMN1; SMN2ALDH1A1
SCHEMBL20977767 0.84 ALDH1A1 (0.41) L3MBTL1AKR1C3AKR1C2TUBB1CPS1
SCHEMBL18052945 0.82 AKR1C3 (0.39) AKR1C3AKR1C2TUBB1CPS1CYP1A2
SCHEMBL18053007 0.80 ALDH1A1 (0.35) L3MBTL1AKR1C3AKR1C2TUBB1CPS1
SCHEMBL18052989 0.76 FFAR1 (0.37) TDP1AKR1C3AKR1C2CPS1PTGS2
SCHEMBL20977908 0.74 TUBB1 (0.38) AKR1C3AKR1C2TUBB1HPGDSMN1; SMN2
SCHEMBL20224039 0.74 ABL1 (0.32) AKR1C3AKR1C2TUBB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3261638-B1 PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS NANTBIOSCIENCE INC (US) 2019-05-08 EP disclosed